| 1 | [MOUNJARO] | - | - | - | - | [1] 233 233 💬
|
| 2 | Acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [25] 2 2, 6, 13, 19, 20, 21, 34, 49, 51, 53, 58, 63, 85, 90, 94, 97, 111, 164, 193, 233, 296, 298, 299, 303, 337 💬
|
| 3 | AMX0035 | - | - | - | - | [3] 2 2, 5, 233 💬
|
| 4 | Dantrolene | [1] Dantrolene Dantrolene | [2] Dantrolene sodium
Dantrolene sodium
,
Dantrolene
💬
| - | - | [2] 13 13, 233 💬
|
| 5 | Dantrolene sodium | [1] Dantrolene Dantrolene | [2] Dantrolene sodium
Dantrolene sodium
,
Dantrolene
💬
| - | - | [1] 233 233 💬
|
| 6 | DEFERIPRONE | [1] Deferiprone Deferiprone | [1] Deferiprone
Deferiprone
💬
| - | - | [7] 2 2, 6, 18, 121, 122, 139, 233 💬
|
| 7 | Depakine | - | - | - | - | [2] 102 102, 233 💬
|
| 8 | DEPAKINE CHRONO 500 mg | - | - | - | - | [1] 233 233 💬
|
| 9 | DEPAKINE CHRONO® 500 mg | - | - | - | - | [1] 233 233 💬
|
| 10 | EXENATIDE | [1] Exenatide Exenatide | [1] Exenatide
Exenatide
💬
| [1] GLP1R GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [6] 6 6, 17, 72, 78, 193, 233 💬
|
| 11 | Metformin | [1] Metformin Metformin | [2] Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| [2] PRKAA1 PRKAA1, PRKAA2 💬
| [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [31] 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
|
| 12 | MOUNJARO | - | - | - | - | [1] 233 233 💬
|
| 13 | MOUNJARO - tirzepatide | [1] Tirzepatide Tirzepatide | [1] Tirzepatide
Tirzepatide
💬
| [2] GIPR GIPR, GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 233 233 💬
|
| 14 | Sitagliptin | [1] Sitagliptin Sitagliptin | [3] Sitagliptin phosphate
Sitagliptin phosphate
,
Sitagliptin
,
Sitagliptin phosphate
💬
| [1] DPP4 DPP4 💬
| [2] Protein digestion and absorption Protein digestion and absorption, Virion - Hepatitis viruses 💬 | [6] 6 6, 63, 75, 77, 233, 299 💬
|
| 15 | Sitagliptin and Metformin | [2] Metformin Metformin, Sitagliptin | [5] Metformin hydrochloride
Metformin hydrochloride
,
Metformin
,
Sitagliptin phosphate
,
Sitagliptin
,
Sitagliptin phosphate
💬
| [3] DPP4 DPP4, PRKAA1, PRKAA2 💬
| [22] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Protein digestion and absorption, Thermogenesis, Tight junction, Virion - Hepatitis viruses, mTOR signaling pathway 💬 | [1] 233 233 💬
|
| 16 | Sodium valproate 200 mg gastro-resistant tablets | - | - | - | - | [1] 233 233 💬
|
| 17 | Sodium Valproate 200Mg E/C Tablet | - | - | - | - | [1] 233 233 💬
|
| 18 | Sodium Valproate Wockhardt 200mg Gastro-Resistant tablets | - | - | - | - | [1] 233 233 💬
|
| 19 | Tirzepatide | [1] Tirzepatide Tirzepatide | [1] Tirzepatide
Tirzepatide
💬
| [2] GIPR GIPR, GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [6] 67 67, 96, 97, 193, 233, 265 💬
|